Patent Application
Utility
App. No. 16/793,391
· Confirmation No. 5783
COMPOSITIONS AND METHODS FOR TREATING PRECOCIOUS PUBERTY
Inventor:
Petr Kuzma
Applicant:
Endo Pharmaceuticals Solutions Inc.
Abandoned -- Failure to Respond to an Office Action
View Publication ↗
|
⬇ PDF
|
Code | Description | Pages | ||
|---|---|---|---|---|---|
| 2021-06-01 | ABN |
Abandonment | 2 | View | |
| 2021-05-24 | WFEE |
Fee Worksheet (SB06) | 2 | View | |
| 2021-05-24 | N417 |
Electronic Filing System Acknowledgment Receipt | 2 | View | |
| 2020-11-24 | CTFR |
Final Rejection | 19 | View | |
| 2020-11-24 | SRFW |
Search information including classification, databases and other search related notes | 1 | View | |
| 2020-11-24 | 1449 |
List of References cited by applicant and considered by examiner | 12 | View | |
| 2020-11-24 | SRNT |
Examiner's search strategy and results | 1 | View | |
| 2020-11-24 | 1449 |
List of References cited by applicant and considered by examiner | 4 | View | |
| 2020-11-24 | SRNT |
Examiner's search strategy and results | 12 | View | |
| 2020-11-24 | BIB |
Bibliographic Data Sheet | 1 | View | |
| 2020-06-11 | NTC.PUB |
Notice of Publication | 1 | View | |
| 2020-03-11 | IDS |
Information Disclosure Statement (IDS) Form (SB08) | 4 | View | |
| 2020-03-11 | N417 |
Electronic Filing System Acknowledgment Receipt | 2 | View | |
| 2020-03-11 | TRAN.LET |
Transmittal Letter | 2 | View | |
| 2020-03-11 | IDS |
Information Disclosure Statement (IDS) Form (SB08) | 12 | View | |
| 2020-03-05 | WFEE |
Fee Worksheet (SB06) | 1 | View | |
| 2020-03-05 | APP.FILE.REC |
Filing Receipt | 4 | View | |
| 2020-02-18 | PA.. |
Power of Attorney | 2 | View | |
| 2020-02-18 | WFEE |
Fee Worksheet (SB06) | 2 | View | |
| 2020-02-18 | N417 |
Electronic Filing System Acknowledgment Receipt | 3 | View | |
| 2020-02-18 | ADS |
Application Data Sheet | 9 | View | |
| 2020-02-18 | DRW |
Drawings-only black and white line drawings | 7 | View | |
| 2020-02-18 | OATH |
Oath or Declaration filed | 1 | View | |
| 2020-02-18 | A.PE |
Preliminary Amendment | 1 | View | |
| 2020-02-18 | SPEC |
Specification | 1 | View | |
| 2020-02-18 | REM |
Applicant Arguments/Remarks Made in an Amendment | 1 | View | |
| 2020-02-18 | SPEC |
Specification | 42 | View | |
| 2020-02-18 | CLM |
Claims | 2 | View | |
| 2020-02-18 | ABST |
Abstract | 1 | View |
Inventors
Petr Kuzma
Princeton, NJ
Attorneys & Agents of Record
Classification
USPC
514/10.6
A61K38/09
A61K9/0024
A61K47/12
A61K47/14
A61K47/32
Prosecution
- Examiner
- ARNOLD, ERNST V
- Art Unit
- 1613
- Customer No.
- 105159
- Docket No.
- EPSI-118US6
- Confirmation No.
- 5783
Publication
- Pub. No.
- US20200179480A1
- Pub. Date
- 2020-06-11
Parent
is a Continuation of
→
App. 16/002,578
Filed 2018-06-07
· Abandoned -- Failure to Respond to an Office Action
Parent
is a Continuation of
→
App. 15/407,632
Filed 2017-01-17
· Abandoned -- Failure to Respond to an Office Action
Parent
is a Continuation of
→
App. 14/935,943
Filed 2015-11-09
· Abandoned -- Failure to Respond to an Office Action
Parent
is a Continuation of
→
App. 14/456,602
Filed 2014-08-11
· Abandoned -- Failure to Respond to an Office Action
Parent
is a Continuation of
→
App. 13/291,764
Filed 2011-11-08
· Abandoned -- Failure to Respond to an Office Action
Parent
is a Division of
→
App. 11/155,822
· US 8,062,652
Filed 2005-06-17
· Patented Case
Parent
Claims priority from a provisional application
→
App. 60/580,520
Filed 2004-06-17
· Provisional Application Expired
Child
is a Continuation of
→
App. 17/328,594
Filed 2021-05-24
· Abandoned -- Incomplete Application (Pre-examination)
Child
is a Continuation of
→
App. 18/244,687
Filed 2023-09-11
· Abandoned -- Incomplete Application (Pre-examination)
Child
is a Continuation of
→
App. 17/492,056
Filed 2021-10-01
· Abandoned -- Incomplete Application (Pre-examination)
Child
is a Continuation of
→
App. 18/077,632
Filed 2022-12-08
· Abandoned -- Incomplete Application (Pre-examination)
Child
is a Continuation of
→
App. 18/742,492
Filed 2024-06-13
· Abandoned -- Incomplete Application (Pre-examination)
Child
is a Continuation of
→
App. 18/419,099
Filed 2024-01-22
· Abandoned -- Incomplete Application (Pre-examination)
Child
is a Continuation of
→
App. 18/138,513
Filed 2023-04-24
· Abandoned -- Incomplete Application (Pre-examination)
Child
is a Continuation of
→
App. 19/069,493
Filed 2025-03-04
· Docketed New Case - Ready for Examination
Child
is a Continuation of
→
App. 17/695,276
Filed 2022-03-15
· Abandoned -- Incomplete Application (Pre-examination)
Child
is a Continuation of
→
App. 17/870,192
Filed 2022-07-21
· Abandoned -- Incomplete Application (Pre-examination)
Child
is a Continuation of
→
App. 18/928,785
Filed 2024-10-28
· Abandoned -- Incomplete Application (Pre-examination)
ACTIENT PHARMACEUTICALS LLC,
ASTORA WOMEN’S HEALTH HOLDINGS, LLC,
ASTORA WOMEN’S HEALTH LLC,
AUXILIUM PHARMACEUTICALS, LLC,
AUXILIUM US HOLDINGS, LLC,
BIOSPECIFICS TECHNOLOGIES CORP.,
BIOSPECIFICS TECHNOLOGIES LLC,
DAVA INTERNATIONAL, LLC,
DAVA PHARMACEUTICALS, LLC,
ENDO GENERIC HOLDINGS, INC. (FORMERLY KNOWN AS PAR PHARMACEUTICALS COMPANIES, INC.),
ENDO PHARMACEUTICALS INC.,
ENDO PHARMACEUTICALS SOLUTIONS INC. (FORMERLY KNOWN AS INDEVUS PHARMACEUTICALS, INC.),
GENERICS BIDCO I, LLC,
GENERICS INTERNATIONAL (US), INC.,
PAR PHARMACEUTICAL, INC.,
PAR STERILE PRODUCTS, LLC (FORMERLY KNOWN AS JHP PHARMACEUTICALS, LLC),
QUARTZ SPECIALTY PHARMACEUTICALS, LLC,
SLATE PHARMACEUTICALS, LLC,
VINTAGE PHARMACEUTICALS, LLC
RELEASE OF SECURITY INTEREST
Recorded 2024-04-26
ACTIENT PHARMACEUTICALS LLC,
ASTORA WOMEN’S HEALTH LLC,
AUXILIUM PHARMACEUTICALS, LLC,
AUXILIUM US HOLDINGS, LLC,
BIOSPECIFICS TECHNOLOGIES CORP.,
BIOSPECIFICS TECHNOLOGIES LLC,
DAVA INTERNATIONAL, LLC,
DAVA PHARMACEUTICALS, LLC,
ENDO PHARMACEUTICALS INC.,
ENDO PHARMACEUTICALS SOLUTIONS INC. (FORMERLY KNOWN AS INDEVUS PHARMACEUTICALS, INC.),
GENERICS BIDCO I, LLC,
GENERICS INTERNATIONAL (US), INC.,
PAR PHARMACEUTICAL, INC.,
PAR PHARMACEUTICAL COMPANIES, INC.,
PAR STERILE PRODUCTS, LLC (FORMERLY KNOWN AS JHP PHARMACEUTICALS, LLC),
QUARTZ SPECIALTY PHARMACEUTICALS, LLC,
SLATE PHARMACEUTICALS, LLC,
VINTAGE PHARMACEUTICALS, LLC
RELEASE OF SECURITY INTEREST
Recorded 2024-04-25
from
ASTORA WOMEN'S HEALTH, LLC,
AUXILIUM US HOLDINGS, LLC,
BIOSPECIFICS TECHNOLOGIES LLC,
ENDO PHARMACEUTICALS SOLUTIONS INC.,
ENDO PHARMACEUTICALS, INC.,
PAR PHARMACEUTICAL, INC.
CONFIRMATORY GRANT OF SECURITY INTEREST IN UNITED STATES PATENTS
Recorded 2021-04-06
from
ASTORA WOMEN'S HEALTH, LLC,
AUXILIUM US HOLDINGS, LLC,
BIOSPECIFICS TECHNOLOGIES LLC,
ENDO PHARMACEUTICALS SOLUTIONS INC.,
ENDO PHARMACEUTICALS, INC.,
PAR PHARMACEUTICAL, INC.
CONFIRMATORY GRANT OF SECURITY INTEREST IN UNITED STATES PATENTS
Recorded 2021-04-06
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded 2020-06-04
MERGER AND CHANGE OF NAME
Recorded 2020-06-04
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this application's details
Quick Facts
- App. No.
- 16/793,391
- Filed
- 2020-02-18
- Pub. No.
- US20200179480A1
- Examiner
- ARNOLD, ERNST V
- Art Unit
- 1613
External Links